News
February 14, 2019
Safety of Long term use of Hydroxychloroquine Therapy Further Verified for People with Lupus
Hydroxychloroquine (Plaquenil®) was approved by the Food and Drug Administration for symptoms of lupus. The greatest concern people with lupus have when taking hydroxychloroquine is related to vision and an increase in risk for retinal damage. A new investigation analyzed the retinal changes over a five-year period in people with lupus and did not find clinically relevant retinal changes in the group. The study concludes that hydroxychloroquine therapy is safe for long-term use at doses <5 mg/kg/day. Learn about how lupus affects the eyes and hydroxychloroquine.
See More:
The latest from Inside Lupus Research
News
Investigational Therapy NKX019 for Lupus Nephritis Treatment Begins Screening Trial Participants
News
Update: Investigational Therapy CABA-201 for Lupus Treatment Shows Positive Initial Data
News
Systemic Lupus Erythematosus Genetics Not Associated with Neonatal Lupus Outcomes
News
Hydroxychloroquine Levels in Women with Systemic Lupus Erythematosus Associated with Flare Activity but Not with Adverse Pregnancy Outcomes